APUS

Apimeds Pharmaceuticals US I Cross-source read
Health CareCUSIP 03771D102

No active 13F manager changed its position in APUS last quarter. No open-market insider trades in the last 180 days.

Tracked 13F holders
4
1 in Q2 2026 filings
13F value (tracked)
$254K
Smart-money readNeutral
Net sellingNet buying
Funds · active managers, latest 13F
0 adding · 0 trimming
Insiders · Form 4 open-market, 180d
0 buying · 0 selling
US House · STOCK Act, 180d
0 buying · 0 selling

No leg leans either way.

Who owns APUS?

4 tracked 13F filers · ranked by shares held

4 tracked 13F filers disclose a position in APUS as of the latest SEC 13F filings, a combined $254K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1Vanguard Capital Management LLC96K
$172K
New filer
Inherited book · not a new buyer
Q1 2026
2Geode Capital Management, LLC35K
$32K
−12%
Reduced · −5K sh
Q2 2026
3Vanguard Fiduciary Trust Co24K
$43K
New filer
Inherited book · not a new buyer
Q1 2026
4UBS Group AG4K
$7K
+619%
Added · +4K sh
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Insider activity (Form 4)

Full insider page →
Net · 180d
$0
0 open-market transactions
DateInsiderRoleActionSharesValue
May 14, 2025Kim ChristopherChairman and CMO, DirectorBuy (P)8K$14K
May 13, 2025Kim ChristopherChairman and CMO, DirectorBuy (P)20K$36K
May 12, 2025Koo JakapDirectorBuy (P)29K$57K

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
11
Insiders
Form 4 open-market
00$0
US House
STOCK Act trades
00$0
Sector rotation
APUS is in Health Care, which smart money is rotating OUT OF
$4.1B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Institutional ownership over time

1 tracked filers in Q2 2026 filingsstill filing
036Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
tracked filers holding their reported valueQ2 2026 filings so far: $32K
Each bar counts tracked filers with a position in that quarter's filings, so the newest bar excludes filers still on an earlier quarter. Arkolith's tracked universe has grown over this window; part of any long-run rise is coverage, not new buyers.

Recent filings

15 most recent

Keep exploring

Connected entities for APUS

Browse more

Build

Ask your agent what changed in APUS

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/APUS/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for APUS.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + the live filing stream, joined for APUS. Filings are public domain, sourced to SEC EDGAR.